The pLGG cell lines with a BRAF V600E mutation showed BRAFi MSSs at the same level as BRAF-mutated melanoma cells and had significantly higher MSSs compared to the pLGG cell lines with a KIAA1549:BRAF-fusion (Fig. 3a and Supplementary Data 5). The gene discussed is BRAF; the disease is melanoma.